Sesh Sundararaman, MD, PhD, discusses his findings and how this approach can be triggered to minimize undesirable treatment features and open the door to newer treatment possibilities.
Sesh Sundararaman, MD, PhD
Advertisement
Sundararaman is an attending physician with the Division of Infectious Diseases at the Children’s Hospital of Philadelphia (CHOP).
Articles by Sesh Sundararaman, MD, PhD
Advertisement
Latest Updated Articles
How a Prodrug Approach May Aid In Antimalarial DevelopmentPublished: March 21st 2025 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
ViiV Healthcare Announces 96-Week PASO DOBLE Results Showing Dovato as Effective as Biktarvy in Maintaining Viral Suppression
2
Top Infectious Disease News Stories Week of October 11-October 17
3
